Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Goldman Sachs increased its price target on Flowserve Corp. to $88 while keeping a Neutral rating, citing greater confidence in margin durability and conversion of longer-cycle backlog after the company's stronger-than-expected fourth-quarter 2025 results and optimistic 2026 guidance. The shares have surged in recent months, pushing valuation metri…
Goldman Sachs has kept a Neutral rating and an $85 price target on Arrowhead Pharmaceuticals (NASDAQ:ARWR), citing the company's recent move into the commercial phase following Redemplo approval for FCS and a slate of potential clinical catalysts in 2026. The bank highlighted a Phase 3 plozasiran SHASTA3/4 readout in severe hypertriglyceridemia exp…
UBS raised its price target on Under Armour, Inc. (UAA) to $11.00 from $8.00 and kept a Buy rating, pointing to the value of the Under Armour brand and expectations that strategic initiatives will lift North America revenue growth. The move comes amid a series of analyst target adjustments and a notable 22.2% stake disclosed by Fairfax Financial. I…
UBS increased its 12-month price target for Tapestry Inc. (TPR) to $141 from $125 while retaining a Neutral rating. The firm pointed to a revitalized Coach brand and improved cost structure as drivers of stronger brand momentum, but noted that much of the positive outlook appears priced in amid elevated valuation metrics and expectations that Coach…
BMO Capital has raised its price target for Biogen Inc. to $196 from $165 while keeping a Market Perform rating, pointing to increased confidence in high-dose Spinraza and anticipated litifilimab trial readouts in systemic lupus erythematosus. The firm balanced that optimism against an expected decline in multiple sclerosis revenue in 2026 and mixe…
Cuba issued a Notice to Aviation (NOTAM) warning that jet fuel will be unavailable on the island from February 10 through March 11. The announcement follows an earlier government rationing plan and comes as shipments from Venezuela have stopped since mid-December amid U.S. actions aimed at restricting Caracas' exports. Airlines operating to Havana …
Crown Holdings' sizable free cash flow and solid return on equity support a buy-rated trade. Valuation metrics - P/E ~13.5, EV/EBITDA ~11.7 and price/free cash flow ~12.7 - leave room for a re-rating if commodity costs stabilize and beverage demand holds. Technicals and dividend support create a favorable entry around $110 with a clear stop under n…
Stocks in Turkey finished higher on Monday, with the BIST 100 index closing up 2.34%. Gains were concentrated in the Wholesale & Retail Trade, Basic Metals and Non-Metal Mineral Products sectors. Market breadth was strongly positive, with rising issues far outnumbering decliners. Commodities and currency markets also moved, with gold futures and cr…
UBS raised its price target on Philip Morris to $181.50 from $158.00 while retaining a Neutral rating. The firm highlighted a modest fourth-quarter EPS beat, stable ZYN and IQOS volumes, and fiscal 2026 EPS guidance that tops consensus, but flagged growth metrics that sit slightly below the company’s mid-term algorithm and guidance that could tempe…
BMO Capital raised its 12-month price objective on NOV Inc. to $20 from $19 while retaining a Market Perform rating following the company's fourth-quarter 2025 results. The move comes amid a mixed set of revisions for 2026 — slightly higher revenue guidance but little change to EBITDA and lower EPS expectations due to higher taxes — and against a b…
Morgan Stanley trimmed its price target on Mettler-Toledo to $1,475 from $1,550 while retaining an Equalweight rating. The reduction follows a revision to the comparative Core Tools peer group and a move to a 25x 2026 EV/EBITDA target multiple. Other brokerages have recently issued higher targets and positive ratings after the company reported stro…
UBS has reiterated a Buy rating and a $77.00 price target on Birkenstock Holding plc ahead of the company’s first-quarter earnings release scheduled for February 12. The bank expects results broadly in line with company pre-announcements and does not foresee a revision to the fiscal 2026 outlook. Multiple other firms and rating agencies have also r…
BMO Capital Partners reduced its 12-month price target for GrafTech (EAF) to $10 from $15 while maintaining a Market Perform rating, citing a Q4 2025 earnings miss and a mixed outlook for 2026. The stock has tumbled sharply in the last week and the company reported deeply negative profitability metrics over the last twelve months and a sizeable net…
Barclays has kept an Equalweight rating and a $68.00 price target on Kroger (KR), describing the appointment of Greg Foran as CEO as an "incremental positive" and characterizing the leadership change as the "best case scenario" given Foran's background and parallels to Walmart at a similar stage of evolution. The bank outlined operational and comme…
Williams Trading raised its price target on Under Armour (NYSE:UAA) to $10.00 from $8.00 and retained a Buy rating, pointing to marketing initiatives designed to build brand loyalty—including a new commercial tied to U.S. Women’s Flag Football—and localized in-store efforts that highlight the company's ties to 3,000 high school football teams. The …
BMO Capital raised its Marathon Petroleum (MPC) price target to $225.00 from $200.00 and kept an Outperform rating after the company reported stronger-than-expected fourth quarter 2025 results and provided optimistic first quarter 2026 guidance. The firm boosted 2026 and later EPS and EBITDA estimates, driven mainly by refining, while trimming its …
BMO Capital raised its price target on Black Hills Corp to $84 from $82 and maintained an Outperform rating, pointing to growing confidence in the utility’s microgrid management fee and potential data center revenue. The firm’s move follows fiscal year results that matched guidance midpoint and 2026 guidance signaling modest earnings growth, even a…
W&T Offshore (WTI) is a small-cap Gulf of Mexico producer with a levered balance sheet and a cheap trading multiple. If oil prices regain momentum, WTI stands to re-rate quickly — but the trade carries execution and credit risk. This plan lays out a mid-term swing trade (45 trading days) that targets a run past last year’s highs while capping downs…
UBS raised its 12-month price objective on CBOE Holdings to $290 from $280 while retaining a Neutral stance. The move comes after the company posted stronger-than-expected trading volumes and quarterly results, prompting upward revisions to UBS's forward estimates even as expected expense reductions tied to business exits have not fully appeared.
Dynatrace reported third-quarter results that beat expectations across key metrics, driving a roughly 9% pre-market increase in the stock. The company delivered above-consensus ARR and revenue growth, maintained healthy unit economics and announced a substantial share-repurchase program expansion while raising full-year fiscal 2026 guidance.
Becton Dickinson (BDX) shares slipped about 5% in pre-market trade after the company reported fiscal Q1 2026 results. While the medical technology firm beat consensus on revenue and adjusted EPS, its fiscal Q2 revenue outlook and ongoing margin questions weighed on investor sentiment. RBC Capital left its Sector Perform rating intact and held a $21…
TD Cowen reaffirmed a Hold rating and a $168 price target for Chevron (CVX), a level below the stock's current trading price and near its 52-week high. The firm emphasized Chevron's emphasis on margin expansion rather than production growth, noted a pause on Venezuela capital allocation for 18-24 months, and highlighted the company’s continued focu…
TD Cowen has reaffirmed a Buy rating and $70.00 price target on Novo Nordisk (NVO) following signals from the FDA that it may clamp down on compounded GLP-1 therapies. The move follows a Department of Justice referral that prompted HIMS to stop selling compounded oral semaglutide. While the development is viewed positively for branded manufacturers…
Slovak central bank governor Peter Kazimir said the European Central Bank would need a significant deviation in economic or inflation trajectories before considering a change in policy, reiterating views days after the ECB left interest rates unchanged and signalled steady policy while expecting inflation to remain near its 2% goal.
Morocco's equity market closed modestly higher on Monday, with the Moroccan All Shares index gaining 0.18% in Casablanca. Gains were concentrated in the Banking, Beverage and Transport sectors. Mining and consumer names produced the session’s strongest individual moves, while several construction and transport-related stocks weighed on the downside…
